Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wroclaw
Clinical trial register · Poland

Clinical Trials in Wroclaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Wroclaw Medical University30 Pfizer29 AstraZeneca26 Eli Lilly and Company22 Janssen Research & Development, LLC20
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Wroclaw

527 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
Self-Powered Photodetectors for Smarter Healthcare
NCT06973317Blood Glucose Monitoring
Wrocław University of Science and Technology
Observational
200
Wroclaw
2027-06
Not yet open
Predicting Declines in Attention and Memory During a Prolonged Mental Task
NCT07877389Mental Fatigue, Cognitive Performance
DSW Ideis University
Not applicable
250
Wroclaw
2026-12
Not yet open
Back Massage Before a Cognitive Task in Healthy Young Adults
NCT07893886Cognitive Performance in Healthy Adults
DSW Ideis University
Not applicable
78
Wroclaw
2026-11
Recruiting
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
NCT07473700Hypertension, Pulmonary, Lung Diseases, Interstitial
Tectonic Operating Company, Inc.
Phase 2
25
Krakow, Lublin, Wroclaw
2026-10-30
Not yet open
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
DrugsZL-1310·Obrixtamig·Atezolizumab
Boehringer Ingelheim
Phase 1/2
60
Brzozów, Wroclaw
2026-10-28
Not yet open
Wroclaw Medical University
Not applicable
25
Wroclaw
2026-10-10
Not yet open
Bristol-Myers Squibb
Phase 3
176
Poznan, Wroclaw, Warsaw, Gdansk, Szczecin, Katowice, Lublin, Zabrze
2026-10-02
Not yet open
Vortosiran in Atrial Fibrillation
NCT07870889Non-valvular Atrial Fibrillation (AF)
DrugsVortosiran·Apixaban
Ribocure Pharmaceuticals AB
Phase 2
150
Katowice, Krakow, Raszyn, Skorzewo, Warsaw, Wroclaw
2026-10-01
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Brzozów, Wroclaw
2026-10-01
Recruiting
Eli Lilly and Company
Phase 3
150
Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Warszewo, Wroclaw
2026-09-25
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Krakow, Lublin, Wroclaw
2026-09-24
Recruiting
AstraZeneca
Phase 3
1,330
Gdansk, Koszalin, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2026-09-15
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Skórzewo, Krakow, Wroclaw, Otwock, Siedlce, Warsaw, Opole, Przemyśl
2026-09-11
Recruiting
T6A Biomarker for Detection of Bacterial Infection in Newborn Infants
NCT07670624Sepsis, Newborn Sepsis, Biomarker Discovery
Salzburger Landeskliniken
Observational
210
Wroclaw
2026-09-03
Not yet open
Philippe ROUSSELOT
Phase 2
93
Wroclaw
2026-09-01
Recruiting
Charite University, Berlin, Germany
Phase 3
750
Wroclaw
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Olsztyn, Warsaw, Węgrów, Wroclaw, Żywiec
2026-09-01
Not yet open
Bruxism Induced by Obstructive Sleep Apnoea.
NCT07511946Sleep Apnea Syndrome, Obstructive, Bruxism, Sleep-Related, Upper Respiratory Tract Illness
Wroclaw Medical University
Observational
80
Wroclaw
2026-09
Not yet open
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in Lumbar Degenerative Disease
NCT07644507Degenerative Lumbar Spine Diseases, Lumbar Spinal Instability, Degenerative Spondylolisthesis, Lumbar Spinal Stenosis
4th Military Clinical Hospital with Polyclinic, Poland
Observational
100
Wroclaw
2026-08-01
Recruiting
VectivBio AG
Phase 3
124
Bydgoszcz, Lublin, Wroclaw
2026-08
Recruiting
AstraZeneca
Phase 3
915
Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
2026-07-16
By invitation
Wrocław University of Science and Technology
Not applicable
40
Wroclaw
2026-07-15
Recruiting
Pfizer
Phase 2
120
Wroclaw
2026-06-30
Recruiting
AstraZeneca
Phase 3
750
Gdansk, Gliwice, Kielce, Lublin, Poznan, Wroclaw
2026-06-26
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730Atypical Hemolytic Uremic Syndrome
DrugRavulizumab
AstraZeneca
Observational
80
Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2026-06-24
Recruiting
AstraZeneca
Phase 3
150
Gdansk, Konin, Krakow, Lodz, Lublin, Poznan, Przemyśl, Wroclaw
2026-06-15
Recruiting
Pfizer
Phase 3
954
Bialystok, Gdansk, Lublin, Poznan, Wroclaw
2026-06-10
Recruiting
Hoffmann-La Roche
Phase 2
120
Warsaw, Bytom, Elblag, Lublin, Nowa Sól, Wroclaw
2026-06-03
Recruiting
4th Military Clinical Hospital with Polyclinic, Poland
Observational
100
Wroclaw
2026-06-01
Recruiting
Bayer
Phase 3
117
Wroclaw, Warsaw, Gdansk, Katowice, Lodz
2026-06-01
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 3
250
Skórzewo, Torun, Wroclaw
2026-05-25
Recruiting
Takeda
Phase 3
300
Wroclaw, Krakow, Warsaw, Katowice, Skorzewo
2026-05-21
Recruiting
Zealand Pharma
Phase 1
36
Wroclaw
2026-05-18
Recruiting
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
NCT07370649Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection, Virologically Suppressed HIV-1 Infection Receiving Long-Acting Antiretroviral Therapy
DrugCabotegravir
Pomeranian Medical University Szczecin
Observational
250
Szczecin, Bydgoszcz, Gdansk, Warsaw, Wroclaw
2026-05-12
Recruiting
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Wroclaw, Gdansk, Krakow, Poznan, Warsaw
2026-05-05
Recruiting
Pfizer
Phase 3
2,400
Krakow, Milówka, Bydgoszcz, Dziekanów Leśny, Poznan, Torun, Trzebnica, Wroclaw
2026-05-04
Recruiting
Enlivex Therapeutics Ltd.
Phase 2
182
Bytom, Katowice, Krakow, Poznan, Radom, Swidnica, Warsaw, Wroclaw
2026-05-01
By invitation
Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
NCT07511959Temporomandibular Disorders (TMD), Muscle Pain, TMJ Pain
Wroclaw Medical University
Observational
68
Wroclaw
2026-05-01
Not yet open
Wroclaw Medical University
Not applicable
30
Wroclaw
2026-05
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
DrugsAsciminib single agent·ABL001
Novartis Pharmaceuticals
Phase 2
50
Gdansk, Wroclaw
2026-04-28
Recruiting
Echosens
Not applicable
149
Wroclaw
2026-04-23
Recruiting
BioMarin Pharmaceutical
Phase 2/3
160
Wroclaw
2026-04-20
Recruiting
Boehringer Ingelheim
Phase 2
405
Bydgoszcz, Krakow, Poznan, Warsaw, Wroclaw
2026-04-20
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugsVisugromab·Visugromab RDE
CatalYm GmbH
Phase 2/3
518
Katowice, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2026-04-16
Recruiting
Eli Lilly and Company
Phase 2
60
Gdansk, Krakow, Ostrowiec Świętokrzyski, Wroclaw
2026-04-14
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
DrugLY4005130
Eli Lilly and Company
Phase 2
66
Gdansk, Krakow, Ostrowiec Świętokrzyski, Wroclaw
2026-04-14
Recruiting
Incyte Corporation
Phase 3
588
Gdansk, Krakow, Warsaw, Wroclaw
2026-04-09
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
400
Poznan, Wroclaw, Warsaw, Gdansk, Szczecin, Katowice, Lublin, Zabrze
2026-04-07
Recruiting
MRM Health NV
Phase 2
204
Bydgoszcz, Katowice, Krakow, Poznan, Sopot, Warsaw, Wroclaw
2026-04-03
Recruiting
Grifols Therapeutics LLC
Phase 3
40
Bydgoszcz, Katowice, Krakow, Wroclaw
2026-04-02
Recruiting
Mage Biologics
Phase 1/2
100
Katowice, Warsaw, Wroclaw
2026-04-01
Recruiting
Michał Pasierbek
Not applicable
120
Wroclaw, Lublin, Warsaw, Krakow, Gdansk, Zabrze, Olsztyn, Kielce
2026-04-01
Recruiting
Yuhan Corporation
Phase 2
150
Poznan, Krakow, Tarnów, Wroclaw, Lublin, Opole, Bialystok, Katowice
2026-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Krakow, Wroclaw, Warsaw, Szczecin
2026-03-24
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Wroclaw, Warsaw, Gdansk
2026-03-16
Active, closed
Sanofi
Phase 3
59
Poznan, Wroclaw, Bielsko-Biala
2026-03-12
Active, closed
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Grodzisk Mazowiecki, Poznan, Wroclaw
2026-03-03
Not yet open
Axon Therapies, Inc.
Not applicable
50
Wroclaw
2026-03-01
Not yet open
Universitat Internacional de Catalunya
Observational
90
Wroclaw
2026-03
Not yet open
Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers
NCT07413419Heart Failure (HF), Self Care, Caregiver, Motivational Interviewing (MI)
Wroclaw Medical University
Not applicable
600
Wroclaw
2026-02-28
Recruiting
AstraZeneca
Phase 3
508
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2026-02-23
Recruiting
ShockFast Intravascular Lithotripsy Device for Treatment of Calcified Coronary Lesions
NCT07407738Coronary Arterial Disease, Calcified Coronary Artery Disease
Shunmei Medical
Not applicable
120
Katowice, Krakow, Lubin, Wroclaw
2026-02-16
Recruiting
Boehringer Ingelheim
Phase 3
286
Krakow, Lodz, Poznan, Szczecin, Warsaw, Wroclaw
2026-02-16
Recruiting
Regional Specialist Hospital in Wroclaw
Not applicable
12,800
Wroclaw
2026-02-16
Recruiting
Pfizer
Phase 2/3
1,156
Katowice, Krakow, Tarnów, Warsaw, Wroclaw, Ostrowiec Świętokrzyski
2026-02-11
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bialystok, Bielsko-Biala, Gdansk, Krakow, Leszno, Poznan, Szczecin, Wroclaw
2026-02-09
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Brzozów, Kielce, Krakow, Lodz, Lublin, Poznan, Torun, Wroclaw
2026-02-08
Recruiting
Corxel Pharmaceuticals
Phase 2
240
Poznan, Bydgoszcz, Krakow, Tarnów, Wroclaw, Lodz, Warsaw, Gdansk
2026-02-06
Recruiting
Eli Lilly and Company
Phase 3
1,980
Bialystok, Krakow, Lodz, Lublin, Poznan, Wroclaw, Zabrze
2026-02-06
Recruiting
Eli Lilly and Company
Phase 3
300
Gdansk, Lodz, Warsaw, Wroclaw
2026-02-05
Recruiting
Exciva GmbH
Phase 2/3
300
Poznan, Krakow, Wroclaw, Lublin, Sochaczew, Warsaw, Katowice, Zabrze
2026-02-02
Not yet open
Spinal Mobility in Children With Cerebral Palsy: NDT-Bobath and Exergaming
NCT07421505Spastic Diplegia Cerebral Palsy, Spastic Hemiplegia
Wroclaw University of Health and Sport Sciences
Not applicable
42
Polanica-Zdrój, Wroclaw
2026-02
Not yet open
Breastmilk and the Link to Overweight/Obesity and Maternal Diet in the Mother-breastmilk-child Triad
NCT07457515Body Weight, Obesity & Overweight, Human Milk/Breastfeeding, Body Composition
Warsaw University of Life Sciences
Observational
165
Wroclaw, Warsaw
2026-02
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Bialystok, Gdansk, Lodz, Poznan, Sosnowiec, Tarnów, Trzebnica, Wroclaw
2026-01-28
Recruiting
Takeda
Phase 2
90
Wroclaw, Warsaw, Rzeszów, Malbork
2026-01-26
Recruiting
BeOne Medicines
Phase 3
500
Brzozów, Katowice, Krakow, Lublin, Wroclaw
2026-01-22
Active, closed
CSL Behring
Phase 2
84
Warsaw, Wałbrzych, Wroclaw
2026-01-22
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Radom, Katowice, Kielce, Lodz, Lublin, Opole, Wroclaw, Tomaszów Mazowiecki
2026-01-06
Recruiting
Navigator Medicines, Inc.
Phase 2
150
Katowice, Kielce, Ossy, Warsaw, Wroclaw
2026-01-05
Not yet open
ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
NCT07336563Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic Syndrome, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus
Jarosław Drobnik
Observational
10,000
Wroclaw
2026-01-05
Recruiting
Wroclaw Medical University
Observational
100
Wroclaw
2026-01-01
Not yet open
Wroclaw Medical University
Not applicable
610
Wroclaw
2026-01-01
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Rzeszów, Warsaw, Wroclaw, Zabrze
2026-01-01
Active, closed
Kailera
Phase 3
1,270
Krakow, Warsaw, Gdynia, Chorzów, Bydgoszcz, Wroclaw, Kielce
2025-12-30
Active, closed
UCB Biopharma SRL
Phase 2
165
Chorzów, Katowice, Krakow, Lodz, Sosnowiec, Tarnów, Warsaw, Wroclaw
2025-12-29
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Wroclaw, Rzeszów, Olsztyn
2025-12-22
Recruiting
Sanofi
Phase 3
85
Poznan, Wroclaw, Warsaw
2025-12-18
Recruiting
AstraZeneca
Phase 2
320
Krakow, Torun, Warsaw, Wroclaw
2025-12-15
Recruiting
Hoffmann-La Roche
Phase 2
160
Bytom, Elbl?g, Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2025-12-05
By invitation
RVU120 Rollover Study
NCT06987058Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome
DrugsRVU120·Ruxolitinib
Ryvu Therapeutics SA
Phase 2
14
Chorzów, Gdansk, Katowice, Krakow, Wroclaw
2025-12-04
Recruiting
Takeda
Phase 3
110
Wroclaw, Lublin, Rzeszów, Gdansk, Lodz
2025-12-04
Recruiting
Ventus Therapeutics U.S., Inc.
Phase 2
24
Bialystok, Oświęcim, Poznan, Rzeszów, Śląskie, Warsaw, Wroclaw
2025-12-03
Recruiting
Bristol-Myers Squibb
Phase 3
650
Poznan, Bydgoszcz, Chorzów, Katowice, Krakow, Lublin, Sochaczew, Wroclaw
2025-12-02
Recruiting
Debiopharm International SA
Phase 3
119
Bydgoszcz, Gliwice, Krakow, Poznan, Wroclaw
2025-11-26
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Katowice, Warsaw, Wroclaw
2025-11-19
Recruiting
Bayer
Phase 3
111
Wroclaw, Warsaw, Katowice, Lódz
2025-11-19
Active, closed
Pfizer
Phase 2
128
Wroclaw, Gdansk, Ostrowiec Świętokrzyski, Rzeszów, Sosnowiec, Szczecin, Warsaw
2025-11-13
Recruiting
Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions
NCT07617376Myocardial Infarction, Decompensated Chronic Heart Failure, Acute Heart Failure (AHF), Pulmonary Embolism Acute
DrugInfluenza vaccination
Wroclaw Medical University
Phase 4
400
Wroclaw
2025-11-12
Recruiting
AstraZeneca
Phase 3
420
Kielce, Krakow, Lodz, Lublin, Wroclaw
2025-11-11
Recruiting
Sanofi
Phase 2
208
Wroclaw, Lodz, Warsaw
2025-11-06
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Krakow, Wroclaw, Warsaw, Otwock, Rzeszów, Gdansk, Brzozów, Lodz
2025-11-03
Recruiting
Takeda
Phase 2
200
Osielsko, Wroclaw, Szczecin, Katowice, Rzeszów, Warsaw, Lodz, Kielce
2025-11-03
Active, closed
Bluefin Biomedicine, Inc.
Phase 2/3
210
Bialystok, Lublin, Wroclaw
2025-11-03
Not yet open
Normobaric Oxygen Therapy in Colorectal Cancer Patients
NCT06946004Colorectal Cancer (CRC)
4th Military Clinical Hospital with Polyclinic, Poland
Not applicable
254
Wroclaw
2025-11-01
Active, closed
A Study With CIT-013 in HS Patients
NCT06993233Hidradenitis Suppurativa (HS)
Citryll BV
Phase 2
108
Bialystok, Gdansk, Katowice, Lodz, Poznan, Rzeszów, Wroclaw
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
1,205
Bydgoszcz, Elblag, Grudziądz, Komorniki, Leszno, Puławy, Wroclaw
2025-10-31
Recruiting
Pfizer
Phase 2
200
Warsaw, Chorzów, Gdansk, Lublin, Tarnów, Wroclaw
2025-10-30
Recruiting
Wroclaw University of Health and Sport Sciences
Not applicable
56
Wroclaw
2025-10-13
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Katowice, Warsaw, Wroclaw
2025-10-06
Active, closed
Medical Inventi S.A.
Not applicable
82
Gniezno, Mińsk Mazowiecki, Tychy, Wroclaw
2025-10-01
Not yet open
Better4All Personalized Intervention
NCT06997510Obesity Prevention
Harokopio University
Not applicable
1,022
Wroclaw
2025-10-01
Recruiting
Eli Lilly and Company
Phase 3
1,000
Bydgoszcz, Skórzewo, Szczecin, Warsaw, Wroclaw
2025-09-30
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Sanofi
Phase 3
124
Krakow, Wroclaw, Gdansk
2025-09-26
Recruiting
Lohmann & Rauscher
Not applicable
150
Bialystok, Krakow, Lodz, Lublin, Ostróda, Wroclaw, Zabrze
2025-09-23
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Poznan, Torun, Wroclaw, Lublin, Puławy, Warsaw, Rzeszów, Bialystok
2025-09-22
Recruiting
Sanofi
Phase 3
942
Wroclaw, Piaseczno, Bialystok, Katowice, Elblag, Sosnowiec
2025-09-16
Recruiting
Medical University of Silesia
Observational
300
Bialystok, Katowice, Kielce, Opole, Wroclaw
2025-09-15
Recruiting
LEO Pharma
Phase 2
135
Bialystok, Iwonicz-Zdrój, Lodz, Lublin, Rzeszów, Warsaw, Wroclaw
2025-09-11
Recruiting
Pfizer
Phase 3
140
Krakow, Wroclaw, Lublin, Warsaw, Katowice, Rzeszów, Lodz
2025-09-10
Active, closed
Wroclaw University of Health and Sport Sciences
Observational
250
Wroclaw
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Krakow, Otwock, Poznan, Rzeszów, Skorzewo, Tomaszów Mazowiecki, Warsaw, Wroclaw
2025-09-08
Recruiting
BeOne Medicines
Phase 3
500
Gdansk, Kielce, Lodz, Lublin, Olsztyn, Torun, Warsaw, Wroclaw
2025-09-04
Recruiting
Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation
NCT07141745Atrial Fibrillation (AF), Ablation Techniques, Radiofrequency Catheter Ablation, Pulsed Field Ablation
Wroclaw Medical University
Not applicable
250
Wroclaw
2025-08-30
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Krakow, Lodz, Wroclaw
2025-08-28
Active, closed
Triveni Bio
Phase 2
95
Wroclaw, Warsaw, Chorzów, Katowice, Poznan, Sosnowiec
2025-08-26
Active, closed
Hoffmann-La Roche
Phase 2
330
Bialystok, Gdansk, Bydgoszcz, Katowice, Lublin, Tarnów, Warsaw, Wroclaw
2025-08-19
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Krakow, Wroclaw, Warsaw
2025-08-11
Active, closed
Novartis Pharmaceuticals
Phase 2
97
Bialystok, Oświęcim, Wroclaw
2025-08-07
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
NCT06774131Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
UroGen Pharma Ltd.
Phase 3
70
Opole, Gdansk, Bydgoszcz, Katowice, Lublin, Olsztyn, Szczecin, Wroclaw
2025-08-06
Recruiting
Pfizer
Phase 3
400
Bydgoszcz, Krakow, Wroclaw, Warsaw, Opole
2025-08-05
Recruiting
Crystalys Therapeutics
Phase 3
500
Poznan, Krakow, Wroclaw, Plońsk, Sochaczew, Warsaw, Bialystok, Gdynia
2025-08-01
Recruiting
Wroclaw Medical University
Not applicable
90
Wroclaw
2025-08-01
Recruiting
Massage Therapy for Healthcare Staff
NCT07094997Low Back Pain
Wroclaw University of Health and Sport Sciences
Not applicable
60
Wroclaw
2025-07-31
Active, closed
Pfizer
Phase 3
208
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Ossy, Rzeszów
2025-07-31
Recruiting
Eli Lilly and Company
Phase 1/2
68
Katowice, Krakow, Skorzewo, Torun, Wroclaw
2025-07-30
Recruiting
Reprieve Cardiovascular, Inc
Not applicable
400
Bialystok, Lodz, Wroclaw
2025-07-28
Recruiting
Bristol-Myers Squibb
Phase 3
586
Oświęcim, Wroclaw, Lublin, Katowice
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Gliwice, Katowice, Krakow, Warsaw, Wroclaw
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
426
Poznan, Bydgoszcz, Chorzów, Katowice, Krakow, Lublin, Sochaczew, Wroclaw
2025-07-16
Recruiting
Takeda
Phase 3
347
Gmina Świecie, Krakow, Lodz, Wroclaw
2025-07-15
Recruiting
4TEEN4 Pharmaceuticals GmbH
Phase 1/2
90
Bialystok, Katowice, Poznan, Wroclaw
2025-07-13
Active, closed
Sanofi
Phase 2
105
Wroclaw, Bydgoszcz, Chojnice, Katowice, Sopot, Tychy, Warsaw
2025-07-07
Not yet open
Effects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP.
NCT06975345Pain, Musculoskeletal Manipulations, Low Back Pain, Mechanical
Wroclaw University of Health and Sport Sciences
Not applicable
100
Wroclaw
2025-07-02
Recruiting
National Institute of Oncology, Hungary
Not applicable
250
Bialystok, Brzozów, Gliwice, Poznan, Wroclaw
2025-07-01
Recruiting
Wroclaw Medical University
Not applicable
100
Wroclaw
2025-07-01
Recruiting
Wroclaw Medical University
Observational
300
Wroclaw
2025-07-01
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Biała Podlaska, Bielsko-Biala, Krakow, Przemyśl, Warsaw
2025-06-30
Recruiting
Ipsen
Phase 2
132
Katowice, Krakow, Oświęcim, Pabianice, Warsaw, Wroclaw
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Szczecin, Bielsko-Biala, Krakow, Lodz, Przemyśl
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
350
Katowice, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Lublin, Opole, Piotrkow Trybunalski, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw
2025-06-26
Active, closed
Incyte Corporation
Phase 3
580
Lodz, Torun, Warsaw, Wroclaw
2025-06-23
Recruiting
GlaxoSmithKline
Phase 3
981
Poznan, Katowice, Bialystok, Bydgoszcz, Krakow, Rzeszów, Wroclaw
2025-06-20
Active, closed
AbbVie
Phase 3
573
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw, Chojnice, Bytom, Szczecin
2025-06-17
Active, closed
Incyte Corporation
Phase 3
573
Lublin, Poznan, Rzeszów, Wroclaw
2025-06-12
Recruiting
BeOne Medicines
Phase 3
630
Lodz, Torun, Wroclaw
2025-06-11
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bialystok, Bydgoszcz, Gdansk, Kielce, Lodz, Wroclaw
2025-06-04
Recruiting
Sanofi
Phase 2
99
Wroclaw, Krakow, Lublin, Sopot, Warsaw
2025-06-03
Recruiting
Odyssey Therapeutics, Inc.
Phase 2
57
Bydgoszcz, Chojnice, Katowice, Rzeszów, Sopot, Staszów, Warsaw, Wroclaw
2025-06-02
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Krakow, Kłodzko, Lublin, Mysłowice, Warsaw, Wroclaw
2025-06-02
Recruiting
Better4All Personalized Intervention Pilot Study
NCT07120802Obesity Prevention
Harokopio University
Not applicable
490
Wroclaw
2025-06-01
Recruiting
Chiesi Poland Sp. z o.o.
Observational
120
Gdansk, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2025-05-29
Active, closed
Sanofi
Phase 3
1,092
Bydgoszcz, Torun, Krakow, Trzebnica, Wroclaw, Warsaw, Łomianki, Siemianowice Śląskie
2025-05-22
Active, closed
Upstream Bio Inc.
Phase 2
396
Wroclaw, Krakow, Tarnów, Rzeszów, Bialystok, Gdansk, Ostrowiec Świętokrzyski
2025-05-21
Recruiting
Pfizer
Phase 2
252
Poznan, Krakow, Tarnów, Wroclaw, Bychawa, Sosnowiec
2025-05-20
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361Symptomatic Severe Aortic Stenosis
Ceric Sàrl
Not applicable
1,180
Poznan, Szczecin, Warsaw, Wroclaw
2025-05-15
Recruiting
Apogee Therapeutics, Inc.
Phase 2
350
Wroclaw, Lublin, Warsaw, Gdansk, Katowice, Sosnowiec, Szczecin, Krakow
2025-05-14
Active, closed
Gilead Sciences
Phase 1
65
Bialystok, Gdynia, Lodz, Torun, Warszawa Targówek, Wroclaw
2025-05-14
By invitation
Sanofi
Phase 2
71
Poznan, Krakow, Wroclaw, Warsaw, Katowice
2025-05-12
Recruiting
Takeda
Phase 3
225
Poznan, Wroclaw, Katowice, Lodz, Olsztyn
2025-05-06
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bialystok, Bydgoszcz, Piotrkow Trybunalski, Przemyśl, Tarnów, Warsaw, Wroclaw
2025-04-30
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Poznan, Gorlice, Krakow, Wroclaw, Lublin, Bydgoszcz, Katowice, Prabuty
2025-04-24
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2
83
Poznan, Wroclaw, Siedlce, Warsaw, Wołomin, Bydgoszcz, Katowice, Lublin
2025-04-23
Recruiting
Vanda Pharmaceuticals
Phase 3
420
Bydgoszcz, Gdansk, Krakow, Poznan, Wroclaw
2025-04-21
Recruiting
BeOne Medicines
Phase 3
250
Brzozów, Katowice, Krakow, Lodz, Lublin, Wroclaw
2025-04-10
Recruiting
Epygenix
Phase 3
260
Krakow, Wroclaw, Warsaw
2025-04-09
Active, closed
UCB Biopharma SRL
Phase 3
43
Lodz, Warsaw, Wroclaw
2025-04-07
Recruiting
Vifor Pharma, Inc.
Phase 2
36
Wroclaw
2025-04-06
Active, closed
Philip Morris Products S.A.
Not applicable
290
Bialystok, Kajetany, Krakow, Lodz, Sochaczew, Warsaw, Wroclaw
2025-04-02
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
By invitation
Wroclaw Medical University
Observational
102
Wroclaw
2025-04-01
Recruiting
Wroclaw Medical University
Observational
500
Wroclaw
2025-04-01
By invitation
The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin
NCT05961501Myalgia, Muscle Pain, Orofacial Pain, Headache, Tension
Wroclaw Medical University
Phase 2/3
42
Wroclaw
2025-04-01
Recruiting
Eli Lilly and Company
Phase 2
200
Bialystok, Gdansk, Krakow, Lodz, Lublin, Tarnów, Warsaw, Wroclaw
2025-03-28
Recruiting
Assessment of Respiratory Dysfunction in Obesity and the Use of IMT.
NCT07307417Obesity & Overweight, Inflammation, Ventilation Disorders
Wroclaw University of Health and Sport Sciences
Not applicable
40
Wroclaw
2025-03-25
Not yet open
Liveome Inc.
Phase 1
15
Wroclaw
2025-03-24
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
206
Wroclaw, Lublin, Krakow, Rzeszw, Malbork, Bialystok-Podlaskie, Katowice, Warsaw
2025-03-21
Active, closed
Celgene
Phase 3
960
Poznan, Wroclaw, Warsaw, Opole, Gdansk, Bytom, Bydgoszcz, Katowice
2025-03-13
Recruiting
Pfizer
Phase 3
723
Krakow, Oświęcim, Wroclaw, Lublin, Warsaw, Katowice
2025-03-11
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Opole, Warsaw, Wroclaw
2025-03-10
Active, closed
Takeda
Phase 3
601
Bydgoszcz, Krakow, Wroclaw, Gdynia, Częstochowa, Elblag, Poznan, Warsaw
2025-03-10
Recruiting
BeOne Medicines
Phase 3
300
Krakow, Lodz, Lublin, Skorzewo, Wroclaw
2025-03-05
Active, closed
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
NCT06845202Obese or Overweight Healthy Volunteers, Type 2 Diabetes Mellitus (T2DM)
DrugALN-4324
Alnylam Pharmaceuticals
Phase 1/2
105
Gdansk, Tarnów, Warsaw, Wroclaw
2025-03-03
Recruiting
A Study of NTRX-07 in Participants With Alzheimer's Disease
NCT07058688Alzheimer Disease, Mild Cognitive Impairment
NeuroTherapia, Inc.
Phase 2
48
Krakow, Wroclaw
2025-03-01
Recruiting
Bambusa Therapeutics
Phase 1
237
Lodz, Rzeszów, Warsaw, Wroclaw
2025-02-27
Recruiting
Amgen
Phase 3
844
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz
2025-02-25
Recruiting
AbbVie
Phase 3
420
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw
2025-02-13
Active, closed
Sanofi
Phase 3
231
Krakow, Wroclaw, Lublin, Warsaw, Bialystok
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Bydgoszcz, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2025-02-10
Active, closed
AbbVie
Phase 3
468
Poznan, Bydgoszcz, Krakow, Oświęcim, Wroclaw, Katowice
2025-02-10
Active, closed
Sanofi
Phase 3
216
Poznan, Wroclaw, Lodz, Bielsko-Biala
2025-02-06
Recruiting
LEO Pharma
Phase 3
90
Warsaw, Wroclaw
2025-02-05
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Gdansk, Krakow, Lodz, Poznan, Szczecin, Wroclaw
2025-02-03
Recruiting
AbbVie
Observational
1,200
Poznan, Wroclaw
2025-01-31
Recruiting
Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis
NCT06833749Osteoarthritis in the Knee, Obesity
KeyBioscience AG
Phase 2
600
Bytom, Poznan, Swidnica, Warsaw, Wroclaw
2025-01-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Wroclaw, Lublin, Warsaw, Słupsk, Gliwice, Katowice, Olsztyn
2025-01-27
Recruiting
A Stepped Wedge Cluster Randomised Trial Of Video Versus Direct Laryngoscopy For Intubation Of Newborn Infants
NCT06757543Intubation, Intubation Complications, Infant, Newborn, Infant Respiratory Distress Syndrome
University College Dublin
Not applicable
840
Gdansk, Katowice, Rzeszów, Wroclaw
2025-01-13
Active, closed
Immunovant Sciences GmbH
Phase 2
120
Bialystok, Elblag, Lublin, Nadarzyn, Poznan, Sochaczew, Warsaw, Wroclaw
2025-01-10
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Podlaski, Bydgoszcz, Wroclaw, Krakow, Sochaczew, Warsaw, Bialystok, Gdansk
2025-01-08
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bydgoszcz, Katowice, Krakow, Skórzewo, Wroclaw
2025-01-03
Active, closed
Wroclaw Medical University
Phase 4
200
Wroclaw
2024-12-31
Active, closed
Nutricia Research
Observational
250
Wroclaw
2024-12-20
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
649
Bialystok, Gdansk, Lodz, Maków Podhalański, Poznan, Tarnów, Wroclaw
2024-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Poznan, Bydgoszcz, Krakow, Wroclaw, Warsaw, Gdynia, Bielsko-Biala, Katowice
2024-12-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,380
Poznan, Włocławek, Krakow, Wroclaw, Lublin, Warsaw, Katowice, Szczecin
2024-11-25
Recruiting
UCB Biopharma SRL
Phase 3
450
Katowice, Krakow, Lublin, Poznan, Warsaw, Wroclaw
2024-11-21
Recruiting
Eli Lilly and Company
Phase 3
150
Krakow, Warsaw, Warszewo, Wroclaw
2024-11-18
Recruiting
Eli Lilly and Company
Phase 3
125
Krakow, Lodz, Rzeszów, Stanisławów Pierwszy, Warsaw, Wroclaw
2024-11-18
Active, closed
Pfizer
Phase 3
636
Bydgoszcz, Krakow, Wroclaw, Lublin, Warsaw
2024-11-15
Active, closed
BeOne Medicines
Phase 2
94
Katowice, Krakow, Lublin, Wroclaw
2024-11-14
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Krakow, Lodz, Lublin, Mysłowice, Warsaw, Wroclaw
2024-11-12
Active, closed
argenx
Phase 2
87
Krakow, Lublin, Nowa Sól, Warsaw, Wroclaw
2024-11-11
Active, closed
Amgen
Phase 2
409
Bialystok, Krakow, Lublin, Staszów, Warsaw, Wroclaw
2024-11-07
Recruiting
Wroclaw Medical University
Phase 4
67
Wroclaw
2024-11-02
Active, closed
Angitia Biopharmaceuticals
Phase 2
379
Gdynia, Krakow, Lodz, Warsaw, Wroclaw
2024-10-31
Recruiting
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Poznan, Krakow, Wroclaw, Warsaw, Przemyśl, Gdansk, Olsztyn, Kielce
2024-10-21
Active, closed
Pfizer
Phase 3
600
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Krakow, Lodz, Lublin, Mysłowice, Warsaw, Wroclaw
2024-10-14
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Krakow, Wroclaw
2024-10-14
Active, closed
Gilead Sciences
Phase 3
600
Szczecin, Wroclaw
2024-10-08
Recruiting
LUMENS-1 EU EFS CIP
NCT06761365Aneurysm Cerebral, Bifurcation, Unruptured Intracranial Aneurysm, Saccular Aneurysm
LuSeed Vascular LTD.
Not applicable
30
Katowice, Lodz, Wroclaw
2024-10-07
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Poznan, Krakow, Wroclaw, Lodz, Warsaw, Gdansk, Częstochowa, Katowice
2024-10-04
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Poznan, Wroclaw, Lublin, Otwock, Warsaw, Gdynia, Lodz
2024-09-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Poznan, Gdansk, Iława, Kielce, Lodz, Lublin, Sochaczew, Wroclaw
2024-09-26
Active, closed
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
DrugSotagliflozin
Lexicon Pharmaceuticals
Phase 3
500
Lodz, Oświęcim, Wroclaw
2024-09-24
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Poznan, Krakow, Warsaw, Bydgoszcz, Lodz, Wroclaw
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Wroclaw, Gdansk, Katowice, Lodz, Rzeszów, Stanisławow Pierwszy Nieporet, Warsaw, Zabrze
2024-09-17
Active, closed
GCP-Service International West GmbH
Phase 2
41
Katowice, Lodz, Warsaw, Wroclaw
2024-09-10
Active, closed
Tectonic Therapeutic
Phase 2
191
Bialystok, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2024-09-04
Active, closed
Takeda
Phase 3
2,099
Poznan, Krakow, Katowice, Kłodzko, Wroclaw, Lublin, Lódz, Nadarzyn
2024-09-04
Recruiting
GlaxoSmithKline
Phase 1
142
Bydgoszcz, Krakow, Poznan, Warsaw, Wroclaw
2024-09-02
Active, closed
Sanofi
Phase 2
229
Poznan, Krakow, Wroclaw, Warsaw
2024-08-29
Recruiting
Bayer
Phase 3
444
Poznan, Wroclaw, Otwock, Warsaw, Bialystok, Lodz, Kielce
2024-08-28
Active, closed
Gilead Sciences
Phase 3
640
Gdynia, Katowice, Poznan, Siedlce, Wroclaw
2024-08-28
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Bydgoszcz, Chojnice, Krakow, Lublin, Poznan, Sopot, Warsaw, Wroclaw
2024-08-28
Active, closed
Regeneron Pharmaceuticals
Phase 4
120
Krakow, Wroclaw, Warsaw, Bialystok, Gdansk
2024-08-26
Active, closed
Kite, A Gilead Company
Phase 3
452
Warsaw, Wroclaw
2024-08-23
Active, closed
argenx
Phase 2
3
Bialystok, Poznan, Wroclaw
2024-08-20
Active, closed
AbbVie
Phase 3
699
Poznan, Torun, Krakow, Wroclaw, Warsaw, Bialystok, Katowice
2024-08-19
Recruiting
AstraZeneca
Phase 3
620
Bialystok, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Gdansk, Gliwice, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-07
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Łęczna, Poznan, Torun, Wroclaw, Warsaw, Rzeszów, Katowice, Szczecin
2024-08-07
Recruiting
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
NCT06707532Kidney Failure, Acute, Myopathy; Drugs, Heart Arrhythmia, Succinylcholine Sensitivity
DrugsRocuronium·Propofol
4th Military Clinical Hospital with Polyclinic, Poland
Not applicable
32
Wroclaw
2024-08-01
Recruiting
Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland
NCT07109141Atrial Fibrillation (AF), Atrial Flutter, Atrial Tachycardia, Ablation Techniques
Wroclaw Medical University
Observational
500
Wroclaw
2024-08-01
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Poznan, Wroclaw, Lublin, Świdnik, Nowa Sól, Lodz, Warsaw, Gdansk
2024-07-30
By invitation
Viatris Innovation GmbH
Phase 3
680
Bydgoszcz, Częstochowa, Katowice, Poznan, Wroclaw
2024-07-30
Active, closed
UCB Biopharma SRL
Phase 3
89
Lodz, Poznan, Warsaw, Wroclaw
2024-07-29
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Ostrów Wielkopolski, Chrzanów, Wroclaw, Puławy, Rzeszów, Gdynia, Dąbrowa Górnicza, Gliwice
2024-06-25
Active, closed
UCB Biopharma SRL
Phase 3
176
Bialystok, Lodz, Nowa Sól, Rzeszów, Szczecin, Wroclaw
2024-06-25
Active, closed
Mobility of the Cervical Spine in Patients With Unspecific Neck Pain
NCT06642233Manual Therapy, Cervical Spine, Neck Pain
Wroclaw University of Health and Sport Sciences
Observational
100
Wroclaw
2024-06-21
Recruiting
AstraZeneca
Phase 3
240
Bialystok, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2024-06-20
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Biała Podlaska, Gdansk, Katowice, Kielce, Lublin, Wroclaw
2024-06-07
Active, closed
Amgen
Phase 3
563
Gdansk, Poznan, Warsaw, Wroclaw
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Poznan, Bydgoszcz, Torun, Krakow, Nowy Targ, Oświęcim, Jelenia Góra, Wroclaw
2024-06-05
Active, closed
Windtree Therapeutics
Phase 1/2
20
Bialystok, Opole, Wroclaw
2024-06-01
By invitation
European Association of Urology Research Foundation
Observational
20,000
Wroclaw
2024-06-01
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Szczecin, Wroclaw
2024-05-28
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Katowice, Krakow, Lodz, Mysłowice, Warsaw, Wroclaw
2024-05-24
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Wroclaw, Bydgoszcz, Bytom, Warsaw
2024-05-21
Active, closed
AbbVie
Phase 3
421
Wroclaw, Lublin, Gdansk
2024-05-19
Recruiting
Boehringer Ingelheim
Phase 2
175
Bydgoszcz, Olsztyn, Warsaw, Wałbrzych, Wroclaw
2024-05-15
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Krakow, Warsaw, Wroclaw
2024-05-13
Active, closed
Wroclaw Medical University
Not applicable
100
Wroclaw
2024-05-10
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Wroclaw, Lublin, Warsaw, Gdansk, Katowice, Sosnowiec, Szczecin, Krakow
2024-04-29
Recruiting
Eli Lilly and Company
Phase 3
510
Bialystok, Katowice, Kielce, Krakow, Poznan, Warsaw, Wieliczka, Wroclaw
2024-04-29
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Bialystok, Bydgoszcz, Lublin, Przemyśl, Tarnów, Torun, Wieliszew, Wroclaw
2024-04-18
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Bydgoszcz, Rzeszów, Torun, Warsaw, Wroclaw, Zamość
2024-04-17
Active, closed
argenx
Phase 3
119
Bydgoszcz, Katowice, Krakow, Lublin, Wroclaw
2024-04-16
Recruiting
4th Military Clinical Hospital with Polyclinic, Poland
Phase 3
188
Wroclaw, Warsaw
2024-04-15
Active, closed
Celldex Therapeutics
Phase 2
140
Krakow, Gdynia, Katowice, Lublin, Rzeszów, Warsaw, Wroclaw
2024-04-12
Active, closed
Amgen
Phase 3
434
Krakow, Wroclaw, Lublin, Warsaw, Wołomin, Malbork, Bydgoszcz, Katowice
2024-04-08
Not yet open
4th Military Clinical Hospital with Polyclinic, Poland
Not applicable
200
Wroclaw
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
673
Bydgoszcz, Włocławek, Krakow, Oświęcim, Jelenia Góra, Wroclaw, Puławy, Żyrardów
2024-04-01
Active, closed
Takeda
Phase 2
213
Wroclaw, Torun, Bydgoszcz, Warsaw, Szczecin, Lodz, Lublin, Rzeszów
2024-03-29
Recruiting
Italfarmaco
Phase 3
220
Poznan, Wałbrzych, Wroclaw
2024-03-26
Active, closed
AbbVie
Phase 2
156
Torun, Wroclaw, Lublin, Chojnice, Tychy, Szczecin, Ksawerów
2024-03-23
Recruiting
AstraZeneca
Phase 3
100
Lodź, Warsaw, Wroclaw
2024-03-14
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Katowice, Krakow, Lodz, Mysłowice, Warsaw, Wroclaw
2024-03-13
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Bydgoszcz, Gdansk, Katowice, Poznan, Rzeszów, Wroclaw
2024-03-11
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Bialystok, Katowice, Kielce, Krakow, Olsztyn, Warsaw, Wroclaw
2024-03-09
Recruiting
Takeda
Phase 2
268
Torun, Wroclaw, Warsaw, Szczecin, Bydgoszcz, Lodz, Lublin, Poznan
2024-03-05
Recruiting
H. Pylori Screen-and-treat Study in a Population of Young Adults
NCT06275204Gastric Cancer, H Pylori Infection, H Pylori Eradication, H-pylori
University of Latvia
Observational
6,800
Wroclaw
2024-03-04
Recruiting
STICH3C Cardiac Magnetic Resonance Observational Study
NCT07133984Ischemic Left Ventricle Systolic Dysfunction, Multivessel Coronary Artery Disease
Weill Medical College of Cornell University
Observational
230
Wroclaw
2024-03-01
Active, closed
ViiV Healthcare
Phase 3
463
Bydgoszcz, Lodz, Wroclaw
2024-02-21
Active, closed
Incyte Corporation
Phase 3
617
Lublin, Ostrowiec Świętokrzyski, Rzeszów, Warsaw, Wroclaw
2024-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Biała Podlaska, Brzozów, Kielce, Lublin, Szczecin, Wroclaw
2024-01-22
Active, closed
DualityBio Inc.
Phase 3
541
Rzeszów, Torun, Krakow, Poznan, Warsaw, Wroclaw, Lodz
2024-01-18
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Bialystok, Elblag, Krakow, Lodz, Osielsko, Poznan, Warsaw, Wroclaw
2024-01-17
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Warsaw, Biała Podlaska, Gdansk, Katowice, Torun, Wałbrzych, Wroclaw, Zielona Góra
2024-01-05
Recruiting
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750Migraine, Episodic Migraine, Chronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute
Observational
700
Wroclaw
2024-01-02
Recruiting
Wroclaw Medical University
Not applicable
180
Wroclaw
2024-01-01
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Bydgoszcz, Wałbrzych, Wroclaw, Lublin, Krakow, Gdansk, Poznan, Skorzewo
2023-12-28
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Katowice, Krakow, Lodz, Lublin, Poznan, Szczecin, Warsaw, Wroclaw
2023-12-27
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Krakow, Wroclaw, Poznan, Skorzewo, Bydgoszcz, Gdansk, Lublin, Warsaw
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Wałbrzych, Wroclaw, Krakow, Gdansk, Skorzewo, Katowice, Lodz, Lublin
2023-12-12
Active, closed
Gilead Sciences
Phase 2
176
Krakow, Lublin, Poznan, Rzeszów, Sopot, Warsaw, Wroclaw
2023-12-05
Recruiting
Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease
NCT06293157Metastatic Spinal Cord Compression, Metastasis Spine
Copernicus Memorial Hospital
Not applicable
226
Bydgoszcz, Wroclaw, Lodz
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Poznan, Krakow, Wroclaw, Warsaw, Gdansk, Gdynia, Częstochowa, Katowice
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,898
Bydgoszcz, Koszalin, Poznan, Rzeszów, Warsaw, Wroclaw
2023-11-21
Active, closed
Nektar Therapeutics
Phase 2
396
Wroclaw, Warsaw, Rzeszów, Gdansk, Gdynia, Częstochowa, Iława, Katowice
2023-11-15
Active, closed
medac GmbH
Phase 2
49
Wroclaw, Lublin, Poznan
2023-11-13
Active, closed
BeOne Medicines
Phase 3
652
Lodz, Lublin, Poznan, Warsaw, Wroclaw
2023-11-11
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Poznan, Krakow, Wroclaw, Bydgoszcz, Warsaw
2023-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Poznan, Torun, Krakow, Nowy Targ, Wadowice, Wroclaw, Warsaw, Chorzów
2023-10-25
Recruiting
Anna Raciborska
Phase 2
24
Warsaw, Wroclaw
2023-10-24
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Bialystok, Krakow, Lodz, Osielsko, Poznan, Warsaw, Wroclaw
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Bialystok, Elblag, Krakow, Lodz, Osielsko, Poznan, Warsaw, Wroclaw
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Osielsko, Torun, Krakow, Wroclaw, Warsaw, Bialystok, Katowice, Elblag
2023-10-11
Active, closed
Acrotech Biopharma Inc.
Phase 3
504
Wroclaw, Krakow, Warsaw, Lodz
2023-10-04
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Poznan, Bialystok, Krakow, Olsztyn, Warsaw, Wroclaw
2023-10-02
Recruiting
AstraZeneca
Phase 3
800
Bialystok, Gdansk, Gliwice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2023-09-22
Active, closed
Bristol-Myers Squibb
Phase 3
774
Krakow, Warsaw, Bydgoszcz, Lublin, Poznan, Wroclaw
2023-09-11
Active, closed
Boehringer Ingelheim
Phase 2
268
Bialystok, Piaseczno, Świdnik, Warsaw, Wroclaw
2023-09-08
Recruiting
Gilead Sciences
Phase 3
402
Mysłowice, Wroclaw
2023-09-07
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Bialystok, Gdansk, Katowice, Krakow, Warsaw, Wroclaw
2023-09-05
By invitation
Wroclaw Medical University
Observational
102
Wroclaw
2023-09-01
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Bydgoszcz, Koszalin, Warsaw, Wroclaw
2023-08-31
Active, closed
Pfizer
Phase 2
507
Poznan, Krakow, Wroclaw, Katowice, Ostrowiec Świętokrzyski
2023-08-22
Active, closed
Hoffmann-La Roche
Phase 3
459
Wroclaw, Krakow, Lodz, Opole, Poznan, Warsaw
2023-08-08
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Bialystok, Gdansk, Gliwice, Krakow, Olsztyn, Poznan, Warsaw, Wroclaw
2023-07-17
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Trzebnica, Wroclaw, Lodz, Bia?ystok, Bydgoszcz, Chojnice, Gdynia, Grudzadz
2023-06-28
Active, closed
Population Health Research Institute
Not applicable
5,100
Legnica, Lubin, Warsaw, Wroclaw
2023-06-22
By invitation
AbbVie
Phase 3
650
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Wroclaw
2023-06-05
By invitation
The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.
NCT05890911Sleep Apnea, Sleep-Disordered Breathing
Wroclaw Medical University
Observational
100
Wroclaw
2023-06-01
Active, closed
Takeda
Observational
50
Wroclaw, Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Rzeszów, Bystra
2023-05-22
Recruiting
Takeda
Phase 3
240
Krakow, Wroclaw, Warsaw, Rzeszów, Gdansk, Katowice, Szczecin, Lodz
2023-05-16
Recruiting
A Phase 2/3,PSMA-T4, Prostate Cancer
NCT05847166Prostate Cancer
NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom
Not applicable
80
Bydgoszcz, Lodz, Warsaw, Wroclaw
2023-05-10
Recruiting
AbbVie
Phase 3
450
Poznan, Bydgoszcz, Krakow, Lublin, Warsaw, Wroclaw
2023-05-01
Active, closed
Wroclaw Medical University
Observational
150
Wroclaw
2023-04-12
Active, closed
Bayer
Phase 3
985
Bydgoszcz, Kielce, Krakow, Lublin, Warsaw, Wroclaw
2023-04-03
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bialystok, Bydgoszcz, Lublin, Piotrkow Trybunalski, Poznan, Słupsk, Warsaw, Wroclaw
2023-03-23
Recruiting
Can-Fite BioPharma
Phase 3
471
Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
2023-03-15
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Wroclaw, Bydgoszcz, Bytom, Lodz, Warsaw
2023-03-02
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Ruda Śląska, Dąbrówka, Bygdoszcz, Chrzanów, Krakow, Wroclaw, Lublin, Poniatowa
2023-03-01
Recruiting
The Safety and Feasibility of the eLym™ System
NCT05747196Heart; Decompensation, Congestive
WhiteSwell, Limited
Not applicable
70
Wroclaw
2023-02-28
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Poznan, Wroclaw, Warsaw, Krakow, Lublin
2023-02-13
Active, closed
Physical Activity, Posture and Body Composition in Ontogeny
NCT06419829Pediatric Obesity, Postural Balance, Physical Activity
Wroclaw University of Health and Sport Sciences
Observational
1,000
Wroclaw
2023-01-15
Active, closed
Bristol-Myers Squibb
Phase 3
513
Poznan, Krakow, Lublin, Warsaw, Chorzów, Elblag, Szczecin, Wroclaw
2023-01-12
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Opole, Poznan, Wejherowo, Wroclaw, Zabrze
2023-01-10
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Bialystok, Katowice, Ścinawa, Warsaw, Wroclaw
2022-12-23
Recruiting
Taiho Oncology, Inc.
Phase 1
27
Wroclaw
2022-12-23
Active, closed
Incyte Corporation
Phase 3
82
Bydgoszcz, Gdansk, Gdynia, Lublin, Olsztyn, Skórzewo, Warsaw, Wroclaw
2022-12-23
Recruiting
Pfizer
Phase 2
36
Warsaw, Katowice, Krakow, Szczecin, Wroclaw
2022-12-16
Active, closed
Viatris Innovation GmbH
Phase 3
470
Bialystok, Częstochowa, Katowice, Krakow, Lublin, Wroclaw
2022-12-13
Recruiting
AstraZeneca
Phase 3
3,527
Chrzanów, Lodz, Rzeszów, Warsaw, Wroclaw, Łańcut, Łęczna
2022-12-13
Active, closed
Sanofi
Phase 2
187
Włocławek, Wroclaw, Łęczna, Warsaw, Gdynia, Katowice, Tychy, Krakow
2022-11-25
Recruiting
Hoffmann-La Roche
Phase 1/2
65
Wroclaw
2022-11-16
Recruiting
Pfizer
Phase 3
1,060
Wroclaw, Gdansk, Katowice
2022-11-10
Recruiting
Bayer
Phase 3
100
Bialystok, Gdansk, Krakow, Lodz, Warsaw, Wroclaw
2022-11-08
Active, closed
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
NCT05473299End-stage Renal Disease
Xeltis
Not applicable
120
Poznan, Wroclaw
2022-11-04
Active, closed
Almirall, S.A.
Phase 4
447
Lublin, Rzeszów, Warsaw, Wroclaw
2022-10-24
Active, closed
AbbVie
Phase 1
283
Opole, Wroclaw, Lublin, Gdansk
2022-10-20
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Bialystok, Krakow, Lodz, Rzeszów, Szczecin, Torun, Warsaw, Wroclaw
2022-09-27
Active, closed
Biogen
Phase 2/3
450
Kielce, Krakow, Krosno, Lodz, Rzeszów, Warsaw, Wroclaw
2022-09-13
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
429
Gdansk, Katowice, Krakow, Lodz, Wroclaw
2022-09-08
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Katowice, Krakow, Warsaw, Wroclaw
2022-08-30
Active, closed
Sanofi
Phase 2/3
1,856
Torun, Krakow, Tarnów, Wroclaw, Lublin, Lodz, Warsaw, Rzeszów
2022-08-22
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Poznan, Krakow, Wroclaw, Warsaw
2022-08-04
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Bydgoszcz, Katowice, Krakow, Mysłowice, Staszów, Wroclaw
2022-08-03
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Biała Podlaska, Bydgoszcz, Gdansk, Katowice, Krakow, Lublin, Skórzewo, Wroclaw
2022-07-22
Active, closed
Incyte Corporation
Phase 1/2
53
Skórzewo, Krakow, Wroclaw, Warsaw, Opole, Gdynia, Lodz, Olsztyn
2022-07-19
Active, closed
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Gdansk, Poznan, Warsaw, Wroclaw
2022-07-06
Active, closed
Sanofi
Phase 3
531
Krakow, Wroclaw, Lublin
2022-06-23
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
NCT05146336Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
CytoSorbents, Inc
Observational
3,000
Krakow, Wroclaw
2022-06-22
Recruiting
Bristol-Myers Squibb
Phase 2/3
120
Krakow, Wroclaw, Warsaw, Rzeszów, Gdansk, Szczecin, Lodz
2022-05-30
Active, closed
AstraZeneca
Phase 3
644
Bialystok, Bydgoszcz, Lodz, Poznan, Warsaw, Wroclaw
2022-05-16
Recruiting
Actelion
Phase 3
280
Bialystok, Bydgoszcz, Katowice, Lodz, Lublin, Szczecin, Wroclaw
2022-05-04
Active, closed
Pierre Fabre Medicament
Phase 3
815
Gliwice, Konin, Krakow, Poznan, Skórzewo, Warsaw, Wroclaw
2022-05-02
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL)
DrugBexobrutideg
Nurix Therapeutics, Inc.
Phase 1
572
Skórzewo, Krakow, Wroclaw, Warsaw, Katowice, Lublin
2022-04-13
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Brzozów, Bydgoszcz, Gdansk, Krakow, Lodz, Torun, Warsaw, Wroclaw
2022-04-11
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Poznan, Warszawa, Bydgoszcz, Wroclaw, Warsaw, Bialystok, Bytom
2022-03-29
Active, closed
Pfizer
Phase 3
854
Skórzewo, Katowice, Gdansk, Poznan, Warsaw, Wroclaw
2022-03-25
Active, closed
Novo Nordisk A/S
Phase 3
153
Wroclaw, Gdansk, Lublin, Warsaw
2022-03-24
Active, closed
Hoffmann-La Roche
Phase 2
46
Gdansk, Wroclaw
2022-03-22
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Katowice, Krakow, Lubin, Warsaw, Wroclaw
2022-03-16
Active, closed
Sanofi
Phase 3
122
Poznan, Wroclaw, Rzeszów
2022-03-11
Recruiting
Takeda
Observational
70
Wroclaw, Poznan, Krakow, Lublin, Tomaszow Mazowiecki, Warsaw, Gdansk, Katowice
2022-03-08
Recruiting
Pfizer
Phase 3
640
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Katowice
2022-02-28
Recruiting
Merck Sharp & Dohme LLC
Phase 2
40
Wroclaw, Olsztyn
2022-02-22
Active, closed
AstraZeneca
Phase 3
791
Bialystok, Gliwice, Katowice, Lodz, Warsaw, Wroclaw
2022-02-18
Recruiting
Sanofi
Phase 3
284
Krakow, Wroclaw, Warsaw
2022-02-15
Recruiting
Takeda
Phase 3
120
Krakow, Wroclaw, Warsaw, Rzeszów, Gdansk, Katowice, Szczecin, Lodz
2022-02-10
By invitation
Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management
NCT05214924Temporomandibular Disorder, Temporomandibular Joint Disorders, Temporomandibular Arthritis, Temporomandibular Joint Osteoarthritis
DrugsIPRF·Platelet rich plasma·Platelet-Rich Fibrin
Wroclaw Medical University
Phase 2/3
42
Wroclaw
2022-01-24
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Krakow, Wałbrzych, Wroclaw, Lublin, Warsaw, Gdynia, Słupsk, Katowice
2022-01-14
Active, closed
Noema Pharma AG
Phase 2/3
166
Dąbrowa Górnicza, Krakow, Lodz, Lublin, Wroclaw
2022-01-11
Not yet open
Medical University of Gdansk
Phase 2
126
Poznan, Wroclaw, Warsaw, Opole, Gdansk, Gliwice
2022-01-01
Recruiting
Lower Silesia Cardiogenic Shock Initiative
NCT05465200Cardiogenic Shock
Wroclaw Medical University
Observational
50
Wroclaw
2022-01-01
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Wroclaw
2021-12-27
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Wroclaw, Bydgoszcz, Kielce, Lodz, Lublin, Piotrkow Trybunalski, Poznan, Rzeszów
2021-12-16
Recruiting
Taiho Oncology, Inc.
Phase 1
18
Wroclaw
2021-12-15
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Plewiska, Bialystok, Glogow Wielkopolski, Katowice, Lublin, Wroclaw, Zabrze
2021-12-13
Active, closed
Abivax S.A.
Phase 2
203
Krakow, Lublin, Oświęcim, Piotrkow Trybunalski, Poznan, Tarnów, Warsaw, Wroclaw
2021-12-03
Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216Acute Stroke, Ischemic Stroke, Stroke
DiaMedica Therapeutics Inc
Phase 2/3
728
Katowice, Krakow, Warsaw, Wroclaw, Zielona Góra
2021-11-07
Recruiting
Wroclaw Out-Of-Hospital Cardiac Arrest Registry
NCT05132387Out-Of-Hospital Cardiac Arrest
Wroclaw Medical University
Observational
50
Wroclaw
2021-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Gdansk, Katowice, Kielce, Lublin, Warsaw, Wałbrzych, Wroclaw
2021-10-14
Active, closed
Beeline Medicines Corporation
Phase 2
248
Warsaw, Poznan, Wroclaw
2021-10-11
Recruiting
Pfizer
Phase 3
893
Bydgoszcz, Gdansk, Katowice, Poznan, Skorzewo, Warsaw, Wroclaw
2021-10-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Wroclaw, Warsaw, Ód
2021-09-15
Active, closed
Celgene
Phase 1
224
Skórzewo, Gdansk, Krakow, Słomniki, Warsaw, Wroclaw
2021-09-15
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2021-08-19
Active, closed
Inventiva Pharma
Phase 3
1,000
Poznan, Wroclaw, Warsaw, Gdynia, Częstochowa, Katowice, Mysłowice, Gdansk
2021-08-19
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Wroclaw
2021-08-18
Recruiting
medac GmbH
Phase 3
210
Wroclaw, Gliwice
2021-08-16
Active, closed
Pfizer
Phase 3
118
Warsaw, Lodz, Rzeszów, Wroclaw
2021-08-12
By invitation
UCB Biopharma SRL
Phase 3
760
Bialystok, Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Warsaw, Wroclaw
2021-07-27
Active, closed
Bristol-Myers Squibb
Phase 3
729
Bydgoszcz, Warsaw, Gdansk, Elblag, Torun, Wroclaw
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
670
Dąbrówka, Krakow, Nowy Targ, Wroclaw, Lublin, Świdnik, Nadarzyn, Warsaw
2021-07-13
Active, closed
Bristol-Myers Squibb
Phase 2
74
Rzeszów, Wroclaw, Lodz
2021-07-12
Recruiting
University Hospital, Basel, Switzerland
Observational
480
Wroclaw
2021-07-01
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Wroclaw, Warsaw, Rzeszów, Koszalin, Brzeziny
2021-06-25
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Rzeszów, Szczecin, Warsaw, Wroclaw
2021-05-26
Active, closed
Daiichi Sankyo
Phase 3
490
Warsaw, Wroclaw
2021-05-21
Active, closed
Hoffmann-La Roche
Phase 3
761
Krakow, Poznan, Warsaw, Wroclaw
2021-05-03
Recruiting
Pfizer
Phase 3
600
Katowice, Krakow, Poznan, Wroclaw
2021-04-28
Active, closed
Incyte Corporation
Phase 3
654
Brzozów, Katowice, Krakow, Lodz, Lublin, Tomaszów Mazowiecki, Warsaw, Wroclaw
2021-04-15
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Lublin, Gdansk, Krakow, Lodz, Skorzewo, Wroclaw
2021-04-08
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Krakow, Wroclaw, Warsaw, Opole, Gdynia
2021-04-05
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Myslowice, Bydgoszcz, Warsaw, Wroclaw, Staszów
2021-04-01
Recruiting
Bristol-Myers Squibb
Phase 3
153
Krakow, Lodz, Warsaw, Wroclaw
2021-03-23
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Gdynia, Grudziądz, Kobylniki, Koszalin, Krakow, Poznan, Warsaw, Wroclaw
2021-03-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
700
Tarnów, Wroclaw, Dębica, Lodz
2021-03-15
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Skórzewo, Torun, Wroclaw, Lublin, Brzozów, Gdansk, Katowice, Wałbrzych
2021-03-11
Active, closed
Celgene
Phase 3
313
Gdansk, Krakow, Lodz, Poznan, Wałbrzych, Wroclaw
2021-02-25
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Gdansk, Gliwice, Krakow, Wroclaw
2021-02-23
Active, closed
Anthos Therapeutics, Inc.
Phase 2
1,287
Gdynia, Chrzanów, Krakow, Wroclaw, Żarów, Lublin, Zamość, Płock
2021-02-02
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Gdansk, Gliwice, Poznan, Warsaw, Wroclaw
2021-02-01
Recruiting
Pfizer
Phase 3
2,100
Wroclaw, Katowice, Krakow, Poznan, Szczecin
2021-01-15
Active, closed
Genmab
Phase 3
483
Gdansk, Katowice, Krakow, Lodz, Skorzewo, Wroclaw
2021-01-13
Active, closed
BioNTech SE
Phase 2/3
358
Gdansk, Gliwice, Konin, Wroclaw
2021-01-07
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Krakow, Wroclaw, Warsaw, Bialystok, Bydgoszcz, Poznan, Sochaczew, Torun
2020-12-22
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Siedlce, Skorzewo, Warsaw, Wroclaw
2020-12-07
Active, closed
Amgen
Phase 3
135
Warsaw, Wroclaw
2020-12-04
Active, closed
Bayer
Phase 4
654
Krakow, Wroclaw, Lublin, Warsaw, Koszalin
2020-11-09
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Krakow, Gdansk, Katowice, Warsaw, Wroclaw
2020-11-04
Active, closed
Acerta Pharma BV
Phase 3
611
Gdansk, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2020-10-08
Active, closed
GlaxoSmithKline
Phase 3
302
Bydgoszcz, Gdansk, Krakow, Lodz, Wroclaw
2020-10-01
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Krakow, Wroclaw, Gdynia, Katowice, Lodz, Opole, Skorzewo, Warsaw
2020-09-16
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Krakow, Gdynia, Wroclaw, Katowice, Skorzewo, Warsaw
2020-09-03
Active, closed
Hoffmann-La Roche
Phase 3
271
Lublin, Poznan, Warsaw, Wroclaw
2020-08-10
Active, closed
Incyte Corporation
Phase 2
112
Kracow, Lodz, Nowy Sącz, Wroclaw
2020-08-03
Active, closed
AstraZeneca
Phase 3
866
Bydgoszcz, Koszalin, Krakow, Lodz, Rzeszów, Warsaw, Wroclaw
2020-07-24
Active, closed
GlaxoSmithKline
Phase 3
242
Częstochowa, Katowice, Mysłowice, Warsaw, Wroclaw
2020-07-14
Active, closed
Actelion
Phase 3
935
Bialystok, Bydgoszcz, Gdansk, Katowice, Krakow, Szczecin, Warsaw, Wroclaw
2020-06-30
Active, closed
Eli Lilly and Company
Phase 3
996
Poznan, Bydgoszcz, Krakow, Wadowice, Swidnica, Wroclaw, Lublin, Zamość
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
Poznan, Bydgoszcz, Krakow, Ścinawa, Wroclaw, Lublin, Warsaw, Warsawawa
2020-06-19
Active, closed
Epizyme, Inc.
Phase 3
599
Skórzewo, Warsaw, Katowice, Krakow, Torun, Wroclaw
2020-06-11
Active, closed
Actelion
Phase 3
138
Gdansk, Krakow, Poznan, Warsaw, Wroclaw, Zabrze
2020-01-16
Active, closed
Pfizer
Phase 3
1,068
Gliwice, Grudziądz, Mysłowice, Piotrkow Trybunalski, Poznan, Skierniewice, Warsaw, Wroclaw
2019-12-30
By invitation
Relationship Between Selected Parameters and Bruxism
NCT04214561Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain
Wroclaw Medical University
Observational
50
Wroclaw
2019-12-16
Active, closed
CStone Pharmaceuticals
Phase 3
534
Poznan, Wroclaw, Bydgoszcz, Warsaw
2019-12-13
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
NCT04239703Kidney Transplant Rejection
University of Alberta
Observational
300
Bialystok, Bydgoszcz, Gdansk, Katowice, Poznan, Szczecin, Warsaw, Wroclaw
2019-12-01
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Wroclaw, Lodz, Warsaw, Gdansk, Katowice
2019-11-26
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Warsaw, Gdansk, Gdynia, Lodz, Wroclaw
2019-11-13
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Poznan, Krakow, Warsaw, Lublin, Wroclaw
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Poznan, Krakow, Warsaw, Lublin, Wroclaw
2019-10-21
Active, closed
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
NCT04050436Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
DrugsVusolimogene Oderparepvec·Cemiplimab
Replimune, Inc.
Phase 2
231
Gdansk, Krakow, Warsaw, Wroclaw
2019-10-08
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugDecitabine
Taiho Oncology, Inc.
Phase 2
332
Wroclaw
2019-09-30
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Bialystok, Krakow, Otwock, Poznan, Wroclaw
2019-09-23
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Wroclaw, Bialystok, Krakow, Lodz, Poznan, Radom, Rzeszów
2019-09-20
Recruiting
AMAG Pharmaceuticals, Inc.
Phase 3
75
Bydgoszcz, Dębica, Katowice, Rzeszów, Warsaw, Wroclaw
2019-09-18
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Katowice, Krakow, Lodz, Lublin, Warsaw, Wroclaw
2019-09-16
Active, closed
Pfizer
Phase 3
896
Poznan, Wroclaw, Będzin, Bialystok, Gdansk, Gdynia, Jelenia Góra, Lodz
2019-09-05
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Bydgoszcz, Wroclaw, Lublin, Rzeszów, Rybnik, Bia?ystok, Gda?sk, Grodzisk Mazowiecki
2019-08-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Poznan, Bydgoszcz, Tarnów, Wroclaw, Otwock, Warsaw, Bialystok, Słupsk
2019-07-24
Active, closed
Amgen
Phase 3
457
Bydgoszcz, Poznan, Warsaw, Wroclaw
2019-07-19
Active, closed
Infant Bacterial Therapeutics
Phase 3
2,158
Szczecin, Warsaw, Wroclaw
2019-07-04
Active, closed
AstraZeneca
Phase 3
923
Bydgoszcz, Konin, Poznan, Racibórz, Radom, Tomaszów Mazowiecki, Warsaw, Wroclaw
2019-06-25
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Bydgoszcz, Koszalin, Krakow, Warsaw, Wroclaw
2019-06-11
Active, closed
AstraZeneca
Phase 3
810
Gdansk, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2019-04-16
Active, closed
Acerta Pharma BV
Phase 3
984
Brzozów, Bydgoszcz, Gdynia, Krakow, Lodz, Lublin, Wroclaw
2019-02-25
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Bydgoszcz, Gdansk, Gdynia, Lodz, Siedlce, Szczecin, Warsaw, Wroclaw
2019-01-25
Active, closed
Kartos Therapeutics, Inc.
Phase 2
20
Wroclaw, Opole
2019-01-15
Active, closed
Celgene
Phase 3
363
Lodz, Gdansk, Lubin, Poznan, Rzwszow, Słupsk, Wałbrzych, Wroclaw
2019-01-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Bydgoszcz, Wroclaw, Ostrołęka, Warsaw, Wieliszew, Bialystok, Gdansk, Gdynia
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Poznan, Torun, Krakow, Tarnów, Wroclaw, Siedlce, Warsaw, Przemyśl
2018-12-24
By invitation
Wroclaw Medical University
Observational
219
Wroclaw
2018-11-01
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Krakow, Wroclaw, Gdansk, Olsztyn
2018-10-04
Recruiting
Vanda Pharmaceuticals
Phase 1
42
Biała Podlaska, Katowice, Krakow, Opole, Skorzewo, Warsaw, Wroclaw
2018-09-27
Active, closed
AstraZeneca
Phase 3
730
Gdansk, Olsztyn, Poznan, Tomaszów Mazowiecki, Warsaw, Wroclaw
2018-09-27
Active, closed
V-Wave Ltd
Not applicable
605
Warsaw, Wroclaw
2018-09-19
Active, closed
AbbVie
Phase 3
1,242
Bydgoszcz, Torun, Krakow, Wroclaw, Warsaw, Sopot, Katowice, Tychy
2018-08-28
Active, closed
Actelion
Phase 2
63
Wroclaw
2018-07-23
Active, closed
Janssen Research & Development, LLC
Phase 3
120
Lodz, Warsaw, Wroclaw
2018-07-11
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Bydgoszcz, Gdansk, Krakow, Słupsk, Warsaw, Wroclaw
2018-06-26
Rows per page Showing 1–500 of 527
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/wroclaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 527 of those studies with a site in Wroclaw.

How many clinical trials are recruiting in Wroclaw?

252 of the 527 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 24 have not yet opened recruitment, 231 are active but closed to new participants, and 20 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wroclaw), 527 studies
PhaseStudiesRecruitingShare
Phase 327412052%
Phase 21004719%
Observational48269.1%
Not applicable47278.9%
Phase 2/321114%
Phase 11382.5%
Phase 1/21382.5%
Phase 41152.1%

Most active sponsors

Lead sponsors with the most studies (Wroclaw)
Lead sponsorStudiesRecruiting
Wroclaw Medical University3012
Pfizer2919
AstraZeneca2616
Eli Lilly and Company2216
Janssen Research & Development, LLC203
Merck Sharp & Dohme LLC179
Sanofi176
AbbVie164
Takeda1510
Novartis Pharmaceuticals146
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.